Top Markets
#1 Tensor Tensor +38.02%
#2 Blur Blur +20.11%
#3 Dymension Dymension +19.49%
#4 Supra Supra +15.93%
#5 XPIN Network XPIN Network +14.16%
#6 Irys Irys +13.12%
#7 Corn Corn +12.16%
#8 Ontology Gas Ontology Gas +12.16%
#9 Naoris Protocol Naoris Protocol +11.04%
#10 Enjin Coin Enjin Coin +9.82%
Coin of the day
Tensor Tensor
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Abbott Laboratories Abbott Laboratories

Abbott Laboratories

ABT
Kedudukan dalam Saham #84
Abbott Laboratories, together with its subsidiaries, discovers, develops,... Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Harga Saham
$101.91
Modal Pasaran
$177.09B
Perubahan (1 hari)
-1.97%
Perubahan (1 tahun)
-19.78%
Negara
US
Perdagangan Abbott Laboratories (ABT)

Kategori

Healthcare
Nisbah P/E bagi Abbott Laboratories (ABT)
Nisbah P/E pada April 2026 TTM: 27.47
Menurut laporan kewangan dan harga saham terkini Abbott Laboratories, nisbah P/E semasa (TTM) ialah 27.47. Pada akhir 2024, syarikat mempunyai nisbah P/E sebanyak 14.62.
Sejarah nisbah P/E bagi Abbott Laboratories dari 2000 hingga 2026
Nisbah P/E pada akhir setiap tahun
Tahun Nisbah P/E Ubah
2026 (TTM) 27.47 -18.12%
2025 33.55 129.56%
2024 14.62 -56.18%
2023 33.35 20.14%
2022 27.76 -21.42%
2021 35.33 -18.19%
2020 43.19 3.69%
2019 41.65 -22.33%
2018 53.63 -74.29%
2017 208.61 416.25%
2016 40.41 170.24%
2015 14.95 -49.70%
2014 29.72 29.04%
2013 23.04 177.98%
2012 8.29 -7.25%
2011 8.93 16.57%
2010 7.66 10.25%
2009 6.95 -13.90%
2008 8.07 -29.75%
2007 11.49 -44.65%
2006 20.76 139.13%
2005 8.68 -19.34%
2004 10.76 -9.48%
2003 11.89 18.37%
2002 10.05 -59.93%
2001 25.07 107.16%
2000 12.10 0.00%
Nisbah P/E untuk syarikat serupa atau pesaing
Syarikat Nisbah P/E Perbezaan Nisbah P/E Negara
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 38.72 40.95%
US
Medtronic plc Medtronic plc
Medtronic plc
2M6.DE
 24.08 -12.35%
IE
Medtronic Medtronic
Medtronic
MDT.US
 24.08 -12.35%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 32.19 17.19%
US
Siemens Healthineers AG Siemens Healthineers AG
Siemens Healthineers AG
SMMNY.US
 19.12 -30.39%
DE
Cara membaca nisbah P/E

Nisbah Harga/Perolehan (P/E) mengukur hubungan antara harga saham syarikat dan pendapatan sesaham.
P/E yang rendah tetapi positif menunjukkan syarikat menjana keuntungan tinggi berbanding dengan penilaian semasa dan mungkin dinilai rendah. P/E negatif yang tinggi (hampir 0) menunjukkan kerugian besar.

Syarikat dengan P/E melebihi 30 atau negatif biasanya dilihat sebagai "saham pertumbuhan", bermaksud pelabur menjangkakan pertumbuhan atau keuntungan masa depan.

Syarikat dengan P/E positif di bawah 10 biasanya dianggap sebagai "saham nilai", bermaksud syarikat sudah menguntungkan dan tidak dijangka berkembang pesat.